Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pandoraon May 18, 2022 1:54pm
158 Views
Post# 34692967

RE:RE:RE:RE:Howie will not leave

RE:RE:RE:RE:Howie will not leave
PeterG wrote:
I personal view is, that this is not the intention from Howard to build a big global company. Again, he is already 60 years old and his intention is to sell the company to the right price. The question in mind is what the right price is if we see two major deals this year: one with Big Pharma and one for pet diabetes? We will see!!


Does that suggest if he was in his mid-70's there might be more of an urgency?
I am over 80 -- time is becoming of the essence for me, I know that. And I wish it was only SBM, not a handful of dead, or presumably dead, horses. And most management is much younger with little apparent concern for time.

That's why they tell me I am supposed to be in dead GIC's. :-)) All perspectives become in the same view! :-))
<< Previous
Bullboard Posts
Next >>